Business Context and Reporting Period
This Form 8-K Current Report, filed on May 12, 2023, covers events occurring on May 11, 2023, following the Annual Meeting of Stockholders for Axcelis Technologies, Inc. The filing details significant corporate governance changes, including executive leadership transitions, board elections, and committee appointments.
Key Financial Metrics
This filing does not contain financial performance data such as revenue, profit, cash flow, margins, debt, or liquidity. The document focuses exclusively on corporate governance and executive compensation arrangements.
Material Changes and Executive Leadership
- CEO Appointment: Russell J. Low, Ph.D., was appointed Chief Executive Officer and President. He previously served as Executive Vice President, Global Customer and Engineering Operations (since 2021) and Executive Vice President, Engineering (2016–2021).
- Former CEO Transition: Mary G. Puma, the former CEO and President, assumed the role of Executive Chairperson of the Board, expected to hold the position until the 2024 Annual Meeting.
- Board Composition: The Board size was fixed at nine members. All nine nominees were elected, with vote percentages ranging from 86.27% to 99.50%.
- Committee Appointments: New committee chairs and members were appointed for Compensation, Audit, Nominating and Governance, and Technology and New Product Development committees.
Compensation and Employment Agreements
Dr. Low entered into a new Employment Agreement dated May 11, 2023, with the following terms:
- Base Salary: $550,333 annually.
- Cash Incentive: Target amount of 87% of base pay for 2023, increasing to 100% thereafter.
- Equity: Participation in the 2023 annual equity program with an anticipated grant date of May 15, 2023.
- Term: Initial term through January 1, 2025, with automatic renewal unless terminated by either party with nine months' prior notice.
- Change of Control: A new agreement increases separation pay on a dual trigger (change of control and termination) to two times the sum of current base salary and target bonus.
Stockholder Vote Results
The Annual Meeting saw 88.35% of eligible shares present. Key vote outcomes included:
- Auditor Ratification: Ernst & Young LLP was ratified with 97.71% of votes cast in favor.
- Executive Compensation (Say-on-Pay): Approved with 97.22% of votes cast in favor.
- Compensation Vote Frequency: Stockholders voted for annual approval (94.65% in favor).
Investor Verification Checklist
- Review the full text of the Employment Agreement (Exhibit 10.1) for specific definitions of "without cause" and "good reason" termination.
- Verify the details of the 2023 annual equity program grant for Dr. Low, anticipated on May 15, 2023.
- Confirm the transition timeline for Mary G. Puma's role as Executive Chairperson leading up to the 2024 Annual Meeting.
- Check subsequent filings for the formal grant of equity awards mentioned in this report.